期刊
CANCERS
卷 14, 期 14, 页码 -出版社
MDPI
DOI: 10.3390/cancers14143528
关键词
pancreatic ductal adenocarcinoma; autophagy; tumor microenvironment; stress; autophagy inhibitors
类别
资金
- Australian Research Training Program Scholarship
- Ramsay PhD Top-up Scholarship
- Australian Rotary Health/Rotary District 9675 `Heather Newbould'/University of Sydney PhD Top-up Scholarship
- Sydney Vital Research Scholar Award
- Caroline Harris Elizabeth Scholarship
- Cancer Institute of New South Wales for his Career Development Fellowship (CINSW) [CDF171147]
- Guy Boncardo
- Pankind Foundation
- Ramsay Research and Teaching Foundation
- Love Your Sister Foundation
- National Breast Cancer Foundation Australia [IIRS-19-058]
This review discusses the importance of the autophagy pathway and tumor microenvironment in pancreatic cancer, as well as novel therapeutic strategies to inhibit autophagy. Pancreatic cancer is characterized by fast growth, invasiveness, and chemo-resistance, with low survival rates. The autophagy pathway plays a crucial role as a survival pathway in pancreatic cancer cells and promotes tumor progression and metastasis. Therefore, investigating therapeutic strategies targeting the autophagy pathway is crucial for overcoming chemo-resistance in pancreatic cancer.
Simple Summary With the mortality rate of pancreatic cancer predicted to rise over the coming years, it is essential that effective treatment strategies are developed as soon as possible. Pancreatic cancer has always proven very difficult to treat due to its fast growing and aggressive nature. Chemotherapeutic treatment has struggled to increase the survival rate of pancreatic cancer patients due to effective chemo-resistant properties that derive from the supporting tumor microenvironment and autophagy, a vital survival pathway. This review will explore how the autophagy pathway and tumor microenvironment help to sustain tumor survival under stress and expand into a metastatic state. Due to the comprehensive understanding of the autophagy pathway, we will highlight the potential chinks in the pancreatic tumor's armor and identify potential targets to overcome chemo-resistance in pancreatic cancer. We will also present novel autophagy inhibitors that could reduce tumor survival and how they could be most effectively conceived. Pancreatic cancer is known to have the lowest survival outcomes among all major cancers, and unfortunately, this has only been marginally improved over last four decades. The innate characteristics of pancreatic cancer include an aggressive and fast-growing nature from powerful driver mutations, a highly defensive tumor microenvironment and the upregulation of advantageous survival pathways such as autophagy. Autophagy involves targeted degradation of proteins and organelles to provide a secondary source of cellular supplies to maintain cell growth. Elevated autophagic activity in pancreatic cancer is recognized as a major survival pathway as it provides a plethora of support for tumors by supplying vital resources, maintaining tumour survival under the stressful microenvironment and promoting other pathways involved in tumour progression and metastasis. The combination of these features is unique to pancreatic cancer and present significant resistance to chemotherapeutic strategies, thus, indicating a need for further investigation into therapies targeting this crucial pathway. This review will outline the autophagy pathway and its regulation, in addition to the genetic landscape and tumor microenvironment that contribute to pancreatic cancer severity. Moreover, this review will also discuss the mechanisms of novel therapeutic strategies that inhibit autophagy and how they could be used to suppress tumor progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据